Financial Statements

Bayer Group Consolidated Income Statements

	1st Quarter 2008	1st Quarter 2009
	€ million	€ million
Net sales	8,536	7,895
Cost of goods sold	(4,103)	(3,786)
Gross profit	4,433	4,109

Selling expenses	(1,902)	(1,960)
Research and development expenses	(633)	(657)
General administration expenses	(419)	(402)
Other operating income	287	134
Other operating expenses	(423)	(251)
Operating result [EBIT]	1,343	973

Equity-method loss	(10)	(13)
Non-operating income	135	283
Non-operating expenses	(400)	(604)
Non-operating result	(275)	(334)

Income before income taxes	1,068	639

Income taxes	(306)	(215)

Income from continuing operations after taxes	762	424

Income from discontinued operations after taxes	0	0

Income after taxes	762	424
of which attributable to non-controlling interest	0	(1)
of which attributable to Bayer AG stockholders (net income)	762	425

Earnings per share (€)

From continuing operations
Basic *	0.96	0.55
Diluted *	0.96	0.55

From discontinued operations
Basic *	0.00	0.00
Diluted *	0.00	0.00

From continuing and discontinued operations
Basic *	0.96	0.55
Diluted *	0.96	0.55
* The ordinary shares to be issued upon conversion of the mandatory convertible bond are treated as already issued shares.